The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
MALDI Imaging Combined with Hierarchical Clustering as a New Tool for the Interpretation of Complex Human Cancers
Open accessAbstract
Proteomics analyses have been exploited for the discovery of novel biomarkers for the early recognition and prognostic stratification of cancer patients. These analyses have now been extended to whole tissue sections by using a new tool, that is, MALDI imaging. This allows the spatial resolution of protein and peptides and their allocation to histoanatomical structures. Each MALDI imaging data set contains a large number of proteins and peptides, and their analysis can be quite tedious. We report here a new approach for the analysis of MALDI imaging results. Mass spectra are classified by hierarchical clustering by similarity and the resulting tissue classes are compared with the histology. The same approach is used to compare data sets of different patients. Tissue sections of gastric cancer and non-neoplastic mucosa obtained from 10 patients were forwarded to MALDI-Imaging. The in situ proteome expression was analyzed by hierarchical clustering and by principal component analysis (PCA). The reconstruction of images based on principal component scores allowed an unsupervised feature extraction of the data set. Generally, these images were in good agreement with the histology of the samples. The hierarchical clustering allowed a quick and intuitive access to the multidimensional information in the data set. It allowed a quick selection of spectra classes representative for different tissue features. The use of PCA for the comparison of MALDI spectra from different patients showed that the tumor and non-neoplastic mucosa are separated in the first three principal components. MALDI imaging in combination with hierarchical clustering allows the comprehensive analysis of the in situ cancer proteome in complex human cancers. On the basis of this cluster analysis, classification of complex human tissues is possible and opens the way for specific and cancer-related in situ biomarker analysis and identification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jain, A. K., Murty, M. N., & Flynn, P. J. (1999) · ACM Computing Surveys · doi:10.1145/331499.331504 · Cited by 13,199
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems
Cornett, D. S., Reyzer, M. L., Chaurand, P., & Caprioli, R. M. (2007) · Nature Methods · doi:10.1038/nmeth1094 · Cited by 886
Schwartz, S. A., Reyzer, M. L., & Caprioli, R. M. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.505 · Cited by 646
Wagner, M. S., & Castner, D. G. (2001) · Langmuir · doi:10.1021/la001209t · Cited by 409
European Code Against Cancer and scientific justification: third version (2003)
Boyle, P., Autier, P., Bartelink, H., Baselga, J., Boffetta, P., Burn, J., Burns, H. J. G., Christensen, L., Denis, L., Dicato, M., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg305 · Cited by 308
Proteomics in Diagnostic Pathology
Chaurand, P., Sanders, M. E., Jensen, R. A., & Caprioli, R. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63367-6 · Cited by 253
McCombie, G., Staab, D., Stoeckli, M., & Knochenmuss, R. (2005) · Analytical Chemistry · doi:10.1021/ac051081q · Cited by 186
Identifying prostate carcinoma by MALDI-Imaging
Schwamborn, K., Krieg, R., Reska, M., Jakse, G., Knuechel, R., & Wellmann, A. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.2.155 · Cited by 168
Crecelius, A. C., Cornett, D. S., Caprioli, R. M., Williams, B., Dawant, B. M., & Bodenheimer, B. (2005) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2005.02.026 · Cited by 162
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
Boyle, P., d’Onofrio, A., Maisonneuve, P., Severi, G., Robertson, C., Tubiana, M., & Veronesi, U. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg353 · Cited by 142
Trim, P. J., Atkinson, S. J., Princivalle, A. P., Marshall, P. S., West, A., & Clench, M. R. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3498 · Cited by 96
Identification of Gastric Cancer Patients by Serum Protein Profiling
Ebert, M. P., Meuer, J., Wiemer, J. C., Schulz, H., Reymond, M. A., Traugott, U., Malfertheiner, P., & Röcken, C. (2004) · Journal of Proteome Research · doi:10.1021/pr049865s · Cited by 90
Self-citation
Cited by
Unsupervised machine learning for exploratory data analysis in imaging mass spectrometry
Verbeeck, N., Caprioli, R. M., & Van de Plas, R. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21602 · Cited by 281
Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry
Rauser, S., Marquardt, C., Balluff, B., Deininger, S.-O., Albers, C., Belau, E., Hartmer, R., Suckau, D., Specht, K., Ebert, M. P., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr901008d · Cited by 276
Self-citationHealth Big Data Analytics: A Technology Survey
Harerimana, G., Jang, B., Kim, J. W., & Park, H. K. (2018) · IEEE Access · doi:10.1109/access.2018.2878254 · Cited by 119
Metadata
- Authors
- Deininger, S.-O., Ebert, M. P., Fütterer, A., Gerhard, M., & Röcken, C.
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-10-23
- Volume
- 7
- Issue
- 12
- Pages
- 5230-5236
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W1974681473
- Cited by
- 266
- References
- 13
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
